Artiva Biotherapeutics, Inc. Common Stock (ARTV)

9.97

(-9.69%)

Operating Expenses Summary of Artiva Biotherapeutics, Inc. Common Stock

  • Artiva Biotherapeutics, Inc. Common Stock's latest annual operating expenses in 2023 was 64.16 Million USD , down -0.92% from previous year.
  • Artiva Biotherapeutics, Inc. Common Stock's latest quarterly operating expenses in 2024 Q1 was 14.74 Million USD , up 2.95% from previous quarter.
  • Artiva Biotherapeutics, Inc. Common Stock reported a annual operating expenses of 64.76 Million USD in annual operating expenses 2022, up 17.16% from previous year.
  • Artiva Biotherapeutics, Inc. Common Stock reported a annual operating expenses of 55.27 Million USD in annual operating expenses 2021, up 202.52% from previous year.
  • Artiva Biotherapeutics, Inc. Common Stock reported a quarterly operating expenses of 14.74 Million USD for 2024 Q1, up 2.95% from previous quarter.
  • Artiva Biotherapeutics, Inc. Common Stock reported a quarterly operating expenses of 64.16 Million USD for 2023 FY, down -0.92% from previous quarter.

Annual Operating Expenses Chart of Artiva Biotherapeutics, Inc. Common Stock (2023 - 2020)

Historical Annual Operating Expenses of Artiva Biotherapeutics, Inc. Common Stock (2023 - 2020)

Year Operating Expenses Operating Expenses Growth
2023 64.16 Million USD -0.92%
2022 64.76 Million USD 17.16%
2021 55.27 Million USD 202.52%
2020 18.27 Million USD 0.0%

Peer Operating Expenses Comparison of Artiva Biotherapeutics, Inc. Common Stock

Name Operating Expenses Operating Expenses Difference